LifeCycle Pharma Publishes 2007 Annual Report

HORSHOLM, Denmark--(Business Wire)--
LifeCycle Pharma A/S (OMX: LCP), an emerging specialty
pharmaceutical company has released its 2007 Annual Report.

Click here
(http://www.businesswire.com/cgi-bin/mmg.cgi?eid=5636384) for a
printable PDF version.

You can also access a copy online at www.lcpharma.com.

About LCP

LCP is an emerging specialty pharmaceutical company, focused on
certain cardiovascular indications and the transplantation market in
particular. The intention is to approach the transplantation market
through our own, hospital based specialist sales force and to use
marketing and sales partners for the cardiovascular indications. We
currently have one product on the market, seven clinical development
programs covering five product candidates and three product candidates
in pre-clinical development. LCP is listed on the OMX Nordic Exchange
under the trading symbol (OMX: LCP). For further information, please
visit www.lcpharma.com.

LifeCycle Pharma A/S
Flemming 0rnskov, MD
President and CEO
Tel.: +45 24 20 03 68
E-mail: fo@lcpharma.com
or
Hans Christian Teisen
Senior Vice President
Tel. +45 36 13 29 70
E-mail: hct@lcpharma.com

Copyright Business Wire 2008